We, then, investigated if the optimized formula (CTX–MEL) was also able to decrease the levels of TNF-α, an additional pro-inflammatory cytokine often implicated in the chronic inflammation observed in diabetes [34]. The gene discussed is TNF; the disease is diabetes mellitus.